MarketPulse

acquisition rumors

2 articles
BenzingaBenzinga··Vandana Singh

Nanobiotix Shoots Down J&J Acquisition Rumors, Stock Soars on Clarity

Nanobiotix denies J&J acquisition rumors, shares rise 6.17%. Stock up 774.83% annually; reaffirms focus on advancing cancer pipeline, NBTXR3 partnership.
JNJNBTXcancer treatmentbiotechnology
BenzingaBenzinga··Vandana Singh

Abivax Dismisses M&A Speculation, Plans Capital Raise Before Trial Readout

Abivax CEO dismisses acquisition rumors, plans equity and debt raise after Phase 3 obefazimod data in Q2 2026. $614.42M cash runway supports strategy.
LLYAZNABVXFDA approvalbiotech